MULTI-VITAMIN WITH IRON AND FLUORIDE 0.25mg CHEWABLE TABLETS
- Manufacturer
- Trigen Laboratories, Inc.
- Effective date
- 2013-01-30
- Label type
- DIETARY SUPPLEMENT
- Version
- 1
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 01:41:41
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
STATEMENT OF IDENTITY SECTION
Rx Only
DESCRIPTION
Chewable tablets containing multivitamins with iron and fluoride 0.25 mg are sugar free, dye free, off-white speckled, round shape, fruit flavor chewable tablets debossed TL on one side and 530 on the other.
| Serving Size: 1 Chewable Tablet | % Daily Value Adults & Children 4 Years or More | |
|---|---|---|
| Amount Per Tablet | ||
| Vitamin A | 1000 IU | 20% |
| Vitamin C | 100 mg | 180% |
| Vitamin D | 400 IU | 100% |
| Vitamin E | 30 IU | 100% |
| Thiamine | 1.5 mg | 100% |
| Riboflavin | 1.7 mg | 100% |
| Niacin | 20 mg | 100% |
| Vitamin B6 | 2 mg | 100% |
| Folic Acid | 400 mcg | 100% |
| Vitamin B12 | 9 mcg | 150% |
| Biotin | 45 mcg | 15% |
| Pantothenic Acid | 10 mg | 100% |
| Iron | 7.5 mg | 42% |
| Magnesium | 60 mg | 15% |
| Zinc | 7.5 mg | 50% |
| Copper | 1 mg | 50% |
| Fluoride | 0.25 mg | * |
* Daily value not established. Ingredient for caries prophylaxis: *Fluoride as sodium fluoride.
Inactive ingredients: Xylitol, Carregeenan, Microcrystalline Cellulose, Natural Fruit Flavor, Citric Acid, Croscarmellose Sodium, Silicon Dioxide, Crospovidone, Magnesium Stearate, Sucralose.
PHARMACOLOGY
It is well established that fluoridation of the water supply (1 ppm fluoride) during period of tooth development leads to a significant decrease in the incidence of dental caries. TL-Fluorivite Chew multi-vitamin with Iron and Fluoride Chewable Tablets provide sodium fluoride, magnesium, zinc, copper, twelve essential vitamins, and iron in a chewable tablet. Because tablets are chewable, they provide a topical as well as systemic source of fluoride.
Hydroxyapatite is the principal crystal for all calcified tissue of the human body. The fluoride ion reacts with the hydroxyapatite in the tooth as it is formed to produce the more caries-resistant crystal fluorapatite. The reaction may be expressed by the equation:
| Ca10(PO4)6(OH)2 + 2F- →Ca10(PO4)F2 + 2OH- | |
| (Hydroxyapatite) | (Flourapatite) |
Three stages of fluoride deposition in tooth enamel can be distinguished:
- Small amounts (reflecting the low levels of fluoride in tissue fluids) are incorporated into the enamel crystals while they are being formed.
- After enamel has been laid down, fluoride deposition continues in the surface enamel. Diffusion of fluoride from the surface inward is apparently restricted.
- After eruption, the surface enamel acquires fluoride from water, food supplementary fluoride and smaller amounts from saliva.
TL-Fluorivite Chew multi-vitamin with Iron and Fluoride Chewable Tablets is a prescription product for the dietary management of the metabolic processes of caries prophylaxis, and provides supplementation of the diet with twelve essential vitamins, magnesium, zinc, copper, and iron.
TL-Fluorivite Chew multi-vitamin with Iron and Fluoride 0.25mg Chewable Tablets provide 0.25 mg of fluoride in tablet form for children 4-6 years of age where the drinking water contains 0.3 through 0.6 ppm of fluoride.
TL-Fluorivite Chew multi-vitamin with Iron and Fluoride Chewable Tablets supply significant amount of Vitamins A,C,D,E, thiamine, riboflavin, niacin, vitamin B6, vitamin B12, folate, biotin, pantothenic acid, magnesium, zinc, copper to supplement the diet, and to help assure that the nutritional deficiencies of these vitamins will not develop. Thus, in a single easy-to-use preparation, children obtain twelve essential vitamins and the important minerals, magnesium, zinc, copper, iron, and fluoride.
The American Academy of Pediatrics recommends that children up to the age of 16, in areas where drinking water contains less than optimal levels of fluoride, receive daily fluoride supplementation.
Children using TL-Fluorivite Chew multi-vitamin with Iron and Fluoride Chewable Tablets regularly should receive semiannual dental examinations. The regular brushing of teeth and attention to good oral hygiene practices are also essential.
WARNINGS SECTION
| WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poising in children under age 6. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or Poison Control Center immediately. |
Tablets should be chewed or crushed before they are swallowed.
This product is not recommended for children under age 4 due to risk of choking.
PRECAUTIONS
The suggested dose of TL-Fluorivite Chew multi-vitamin with Iron and Fluoride Chewable Tablets should not be exceeded, since dental fluorosis may result for continued ingestion of large amounts of fluoride.
Before prescribing TL-Fluorivite Chew multi-vitamin with Iron and Fluoride Chewable Tablets:
- Determine the fluoride content of the drinking water form all major sources.
- Make sure the child is not receiving significant amounts of fluoride from other sources such as medications and swallowed toothpaste.
- Periodically check to make sure that the child does not develop significant dental fluorosis.
Your doctor or dentist is the best source of counsel and guidance in your child's fluoride supplementation.
ADVERSE REACTION
Allergic rash and other idiosyncrasies have been rarely reported.
RECOMMENDED USE
One tablet daily or as prescribed by doctor, or dentist.
HOW SUPPLIED
TL-Fluorivite Chew is supplied in child-resistant bottles of 100 chewable tablets.
STORAGE
Store at 25° (77°F); excursions permitted to 15°-30°C (59°-86°F). See USP Controlled Room Temperature. Protect from light and moisture.
SAFE HANDLING WARNING SECTION
KEEP OUT OF REACH OF CHILDREN.
HEALTH CLAIM SECTION
Manufactured For:
TRIGEN Laboratories, Inc.
Sayreville, NJ 08872
www.trigenlab.com
Rev. 09/12
PRINCIPAL DISPLAY PANEL - 100 Tablet Bottle Label
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 13811-530-10 | EA - Each | 13811-530 | 7b4fe6bc-08dc-43cc-821d-f0a8cc1c392c | 1 | 2013-02-19 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| .Alpha.-Tocopherol | ACTIVE INGREDIENT | H4N855PNZ1 | 1 | |
| Ascorbic Acid | ACTIVE INGREDIENT | PQ6CK8PD0R | 1 | |
| Biotin | ACTIVE INGREDIENT | 6SO6U10H04 | 1 | |
| Copper | ACTIVE INGREDIENT | 789U1901C5 | 1 | |
| Cyanocobalamin | ACTIVE INGREDIENT | P6YC3EG204 | 1 | |
| Folic Acid | ACTIVE INGREDIENT | 935E97BOY8 | 1 | |
| Iron | ACTIVE INGREDIENT | E1UOL152H7 | 1 | |
| Magnesium | ACTIVE INGREDIENT | I38ZP9992A | 1 | |
| Niacin | ACTIVE INGREDIENT | 2679MF687A | 1 | |
| Pantothenic Acid | ACTIVE INGREDIENT | 19F5HK2737 | 1 | |
| Pyridoxine | ACTIVE INGREDIENT | KV2JZ1BI6Z | 1 | |
| Riboflavin | ACTIVE INGREDIENT | TLM2976OFR | 1 | |
| Sodium Fluoride | ACTIVE INGREDIENT | 8ZYQ1474W7 | 1 | |
| Thiamine Mononitrate | ACTIVE INGREDIENT | 8K0I04919X | 1 | |
| Vitamin A | ACTIVE INGREDIENT | 81G40H8B0T | 1 | |
| Vitamin D | ACTIVE INGREDIENT | 9VU1KI44GP | 1 | |
| Zinc | ACTIVE INGREDIENT | J41CSQ7QDS | 1 | |
| .Alpha.-Tocopherol | ACTIVE MOIETY | H4N855PNZ1 | 1 | |
| Ascorbic Acid | ACTIVE MOIETY | PQ6CK8PD0R | 1 | |
| Biotin | ACTIVE MOIETY | 6SO6U10H04 | 1 | |
| Copper | ACTIVE MOIETY | 789U1901C5 | 1 | |
| Cyanocobalamin | ACTIVE MOIETY | P6YC3EG204 | 1 | |
| Fluoride Ion | ACTIVE MOIETY | Q80VPU408O | 1 | |
| Folic Acid | ACTIVE MOIETY | 935E97BOY8 | 1 | |
| Iron | ACTIVE MOIETY | E1UOL152H7 | 1 | |
| Magnesium | ACTIVE MOIETY | I38ZP9992A | 1 | |
| Niacin | ACTIVE MOIETY | 2679MF687A | 1 | |
| Pantothenic Acid | ACTIVE MOIETY | 19F5HK2737 | 1 | |
| Pyridoxine | ACTIVE MOIETY | KV2JZ1BI6Z | 1 | |
| Riboflavin | ACTIVE MOIETY | TLM2976OFR | 1 | |
| Thiamine Ion | ACTIVE MOIETY | 4ABT0J945J | 1 | |
| Vitamin A | ACTIVE MOIETY | 81G40H8B0T | 1 | |
| Vitamin D | ACTIVE MOIETY | 9VU1KI44GP | 1 | |
| Zinc | ACTIVE MOIETY | J41CSQ7QDS | 1 | |
| Carrageenan | INACTIVE INGREDIENT | 5C69YCD2YJ | 1 | |
| Cellulose, Microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | 1 | |
| Citric Acid Monohydrate | INACTIVE INGREDIENT | 2968PHW8QP | 1 | |
| Croscarmellose Sodium | INACTIVE INGREDIENT | M28OL1HH48 | 1 | |
| Crospovidone | INACTIVE INGREDIENT | 68401960MK | 1 | |
| Magnesium Stearate | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| Silicon Dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| Sucralose | INACTIVE INGREDIENT | 96K6UQ3ZD4 | 1 | |
| Xylitol | INACTIVE INGREDIENT | VCQ006KQ1E | 1 |
Products#
Every source-derived product name is available through these pages.
- TL-Fluorivite
- Vitamin A, Ascorbic Acid, Vitamin D, .Alpha.-Tocopherol, Thiamine Mononitrate, Riboflavin, Niacin, Pyridoxine, Folic Acid, Cyanocobalamin, Biotin, Pantothenic Acid, Iron, Magnesium, Zinc, Copper, and Sodium Fluoride
- Vitamin A
- Ascorbic Acid
- Vitamin D
- .Alpha.-Tocopherol
- Thiamine Mononitrate
- Thiamine Ion
- Thiamine
- Riboflavin
- Niacin
- Pyridoxine
- Folic Acid
- Cyanocobalamin
- Biotin
- Pantothenic Acid
- Iron
- Magnesium
- Zinc
- Copper
- Sodium Fluoride
- Fluoride Ion
- Xylitol
- Carrageenan
- Cellulose, Microcrystalline
- Citric Acid Monohydrate
- Croscarmellose Sodium
- Silicon Dioxide
- Crospovidone
- Magnesium Stearate
- Sucralose
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 13811-530 | 13811-530-10 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Vitamin A | 81G40H8B0T | ACTIB |
| Ascorbic Acid | PQ6CK8PD0R | ACTIB |
| Vitamin D | 9VU1KI44GP | ACTIB |
| .Alpha.-Tocopherol | H4N855PNZ1 | ACTIB |
| Thiamine Mononitrate | 8K0I04919X | ACTIR |
| Riboflavin | TLM2976OFR | ACTIB |
| Niacin | 2679MF687A | ACTIB |
| Pyridoxine | KV2JZ1BI6Z | ACTIB |
| Folic Acid | 935E97BOY8 | ACTIB |
| Cyanocobalamin | P6YC3EG204 | ACTIB |
| Biotin | 6SO6U10H04 | ACTIB |
| Pantothenic Acid | 19F5HK2737 | ACTIB |
| Iron | E1UOL152H7 | ACTIB |
| Magnesium | I38ZP9992A | ACTIB |
| Zinc | J41CSQ7QDS | ACTIB |
| Copper | 789U1901C5 | ACTIB |
| Sodium Fluoride | 8ZYQ1474W7 | ACTIM |
| Xylitol | VCQ006KQ1E | IACT |
| Carrageenan | 5C69YCD2YJ | IACT |
| Cellulose, Microcrystalline | OP1R32D61U | IACT |
| Citric Acid Monohydrate | 2968PHW8QP | IACT |
| Croscarmellose Sodium | M28OL1HH48 | IACT |
| Silicon Dioxide | ETJ7Z6XBU4 | IACT |
| Crospovidone | 68401960MK | IACT |
| Magnesium Stearate | 70097M6I30 | IACT |
| Sucralose | 96K6UQ3ZD4 | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Croscarmellose Sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET, DELAYED RELEASE PARTICLES / ORAL | 64 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRAMUSCULAR | 26 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | INHALANT / ORAL | 0.08 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | TROCHE / ORAL | 315 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SPRAY / NASAL | 9 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TROCHE / ORAL | 300 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SUSPENSION, EXTENDED RELEASE / ORAL | 70 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / BUCCAL | 18 mg | ||
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | SPRAY / NASAL | 2 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / ORAL | 269 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAVENOUS | 2068 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | CREAM / TOPICAL | NA | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FOR SUSPENSION / ORAL | 20100 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / SUBCUTANEOUS | 28 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / OPHTHALMIC | 0.05 %w/v | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | SYSTEM / INTRAVITREAL | 0.02 mg | ||
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | SOLUTION / ORAL | 800 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SWAB / TOPICAL | 0.05 %w/w | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER, FOR SUSPENSION / ORAL | 2553 mg | ||
| Croscarmellose Sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / SUBLINGUAL | 10 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYSTEM / TOPICAL | 0.2 mg | ||
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | TABLET / ORAL | 45 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | IMPLANT / SUBCUTANEOUS | 0.5 mg | ||
| Croscarmellose Sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET, CHEWABLE / ORAL | 216 mg | ||
| Croscarmellose Sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 127 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | NA | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION, CONCENTRATE / IRRIGATION | 1 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / INTRAVENOUS | 0.2 %w/v | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, DELAYED RELEASE / ORAL | 144 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAVENOUS | 10 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE, FOR SUSPENSION / ORAL | 278 mg | ||
| Croscarmellose Sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | CAPSULE, COATED PELLETS / ORAL | 198 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / TOPICAL | 4 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | FILM, EXTENDED RELEASE / TRANSDERMAL | 1.38 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CREAM / VAGINAL | 51 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, SUGAR COATED / ORAL | NA | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / EPIDURAL | 0.02 %w/v | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TAMPON / VAGINAL | NA | ||
| Xylitol | XYLITOL | VCQ006KQ1E | FILM, SOLUBLE / ORAL | 29 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET / SUBLINGUAL | 17.5 mg | ||
| Carrageenan | CARRAGEENAN | 5C69YCD2YJ | POWDER / RESPIRATORY (INHALATION) | 1 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, COATED / ORAL | 920 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, DELAYED RELEASE PARTICLES / ORAL | 580 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, DELAYED RELEASE / ORAL | 1190 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET / ORAL | 914 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET / SUBLINGUAL | 24 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | GRANULE, FOR SUSPENSION / ORAL | 113 mg | ||
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | TABLET / SUBLINGUAL | 12 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYRUP / ORAL | 722 mg/5ml | ||
| Croscarmellose Sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | GRANULE, FOR SUSPENSION / ORAL | 282 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / TOPICAL | 0.01 %w/v | ||
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | TABLET, EXTENDED RELEASE / ORAL | 1 mg | ||
| Carrageenan | CARRAGEENAN | 5C69YCD2YJ | LOTION / TOPICAL | 0.5 %w/w | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAMUSCULAR | 0.05 %w/v | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | EMULSION / TOPICAL | 0.11 %w/w | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, DELAYED RELEASE / ORAL | 366 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | DROPS / ORAL | NA | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SOLUTION / TOPICAL | NA | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAMUSCULAR | 28 mg |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
